Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan

References

• Aikawa K, Matsumoto K, Uda H, Tanaka S, Shimamura H, Aramaki Y, Tsuchiya S.(1998). Prolonged release of drug from O/w emulsion and residence in rat nasal cavity. Pharm Dev Technol. 3: 461–469.
   PubMedGoogle Scholar
• Arora, P., Sharma, S., Garg, S. (2002). Permeability issues in nasal drug delivery. Drug Discov Today. 7: 967–975.
   PubMed Web of Science ®Google Scholar
• Chen, J., Wang, X., Wang, J., Liu, G., Tang, X. (2008). Evaluation of brain-targeting for the nasal delivery of ergoloid mesylate by the microdialysis method in rats. Eur J Pharm Biopharm. 68: 694–700.
   PubMed Web of Science ®Google Scholar
• Dahlöf, C.G.H., Linde, M., Kerekes, E. (2004). Zolmitriptan nasal spray provides fast relief of migraine symptoms and is preferred by patients: a Swedish study of preferencein clinical practice. J Headache Pain. 5: 237–242.
   Google Scholar
• Dai, H.Q., Elmquist, W.F. (2003). Drug Transport Studies Using. In Nag S, editor. The blood-brain barrier: biology and research protocols, Totowa: Humama Press. p 249–264.
   Google Scholar
• Daugherty, A.L., Liggitt, H.D., McCabe, J.G., Moore, J.A., Patton, J.S. (1988). Absorption of recombinant methionyl-human growth hormone (Met-hGH) from rat nasal mucosa. Int J Pharm. 45: 197–206.
   Web of Science ®Google Scholar
• Hirai, S., Yashiki, T., Matsuzawa, T., Mima, H. (1981). Absorption of drugs from the nasal mucosa. Int J Pharm. 7:317–325.
   Web of Science ®Google Scholar
• Huang, C.H., Kimura, R., Nassar, R.B., Hussain, A. (1985). Mechanism of nasal absorption of drugs. I. Physicochemical parameters influencing the rate of in situ nasal absorption of drugs in rats. J Pharm Sci. 74:608–611.
   Google Scholar
• Illum, L. (2000). Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci.11:1–18.
   PubMed Web of Science ®Google Scholar
• Jadhav Kisan, R., Gambhire Manoj, N., Shaikh Ishaque, M., Kadam Vilarsrao, J., Pisal Sambjahi, S. (2007). Nasal Drug Delivery System-Factors Affecting and Applications. Current Drug Therapy. 2:27–38.
   Google Scholar
• Jain, R., Nabar, S., Dandekar, P., Patravale, V. (2010). Micellar nanocarriers: potential nose-to-brain delivery of zolmitriptan as novel migraine therapy. Pharm Res. 27: 655–664.
   PubMed Web of Science ®Google Scholar
• Jensen, S.M., Hansen, H.S., Johansen, T., Malmlöf, K. (2007). In vivo and in vitro microdialysis sampling of free fatty acids. J Pharm Biomed Anal. 43:1751–1756.
   PubMed Web of Science ®Google Scholar
• Jumaa, M., Muller, B.W. (2002). Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxystearate: evaluation of accelerated and long-term stability. Eur J Pharm Biopharm. 54: 207–212.
   PubMed Web of Science ®Google Scholar
• Kawakami, K., Yoshikawa, T., Hayashi, T., Nishihara,Y., Masuda, K. (2002). Microemulsion formulation for enhanced absorption of poorly soluble drugs. II. In vivo study. J. Control. Release 81: 75–82.
   PubMed Web of Science ®Google Scholar
• Komatsu, H., Kitajima, A., Okada, S. (1995). Pharmaceutical characterization of commercially available intravenous fat emulsions: estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy. Chem Pharm Bull 43:1412–1415.
   PubMed Web of Science ®Google Scholar
• Lipton, R.B., Hamelsky, S.W., Dayno, J.M. (2002). What do patients with migraine want from acute migraine treatment? Headache. 42:3–9.
   PubMed Web of Science ®Google Scholar
• Lipton, R.B., Stewart, W.F. (1999). Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache. 39:20–26.
   Google Scholar
• Liu, X., Zhang, Y., Tang, X., Zhang, H. (2009). Determination of entrapment efficiency and drug phase distribution of submicron emulsions loaded silybin. J Microencapsul. 26:180–186.
   PubMed Web of Science ®Google Scholar
• MacGregor, E.A., Brandes, J., Eikermann, A. (2003). Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation Survey. Headache. 43:19–26.
   PubMed Web of Science ®Google Scholar
• Mano, Y., Higuchi, S., Kamimura, H. (2002). Investigation of the high partition of YM992, a novel antidepressant, in rat brain - in vitro and in vivo evidence for the high binding in brain and the high permeability at the BBB. Biopharm Drug Dispos. 23:351–360.
   PubMed Web of Science ®Google Scholar
• Mathison, S., Nagilla, R., Kompella, U.B. (1998). Nasal route for direct delivery of solutes to the central nervous system: fact or FFFFFB01ction? J Drug Target. 5: 415–441.
   PubMed Web of Science ®Google Scholar
• Mayor, S.H., Illum, L. (1997). Investigation of the effect of anaesthesia on nasal absorption of insulin in rats. Int J Pharm. 149: 123–129.
   Web of Science ®Google Scholar
• Mitra, R., Pezron, I., Chu, W.A., Mitra, A.K. (2000). Lipid emulsions as vehicles for enhanced nasal delivery of insulin. Int J Pharm. 205:127–134.
   PubMed Web of Science ®Google Scholar
• Pascual, J., Muñoz, R., Leira, R. (2001). An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients. Cephalalgia. 21:680–684.
   PubMed Web of Science ®Google Scholar
• Paxinos, G., Watson, C. (1998). The rat brain in stereotaxic coordinates, CD-ROM. 4th ed. San Diego: Academic Press.
   Google Scholar
• Qiao, J.P., Abliz, Z., Chu, F.M., Hou, P.L., Zhao, L.Y., Xia, M., Chang, Y., Guo, Z.R. (2004). Microdialysis combined with liquid chromatography-tandem mass spectrometry for the determination of 6-aminobutylphthalide and its main metabolite in the brains of awake freely-moving rats. J Chromatogr B Analyt Technol Biomed Life Sci. 805:93–99.
   PubMed Web of Science ®Google Scholar
• Rapoport, A.M., Bigal, M.E., Tepper, S.J., Sheftell, F.D. (2004). Zolmitriptan (ZOMIG). Expert Rev Neurother. 4:33–41.
   PubMedGoogle Scholar
• Rance, D., Clear, N., Dallman, L., Llewellyn, E., Nuttall, J., Verrier, H. (1997). Physicochemical comparison of eletriptan and other 5-HT1D-like agonists as a predictor of oral absorption potential. Headache 37:328.
   Google Scholar
• Spencer, C.M., Gunasekara, N.S., Hills, C. (1999). Zolmitriptan: a review of its use in migraine. Drugs. 58:347–374.
   PubMed Web of Science ®Google Scholar
• Thorne, R.G.., Pronk, G.J., Padmanabhan, V., Frey, W.H. (2004). Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience. 127: 481–496.
   PubMed Web of Science ®Google Scholar
• Vyas, T.K., Babbar, A.K., Sharma, R.K., Misra, A. (2005). Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting. J Drug Target. 13:317–324.
   PubMed Web of Science ®Google Scholar
• Wang, X., He, H., Leng, W., Tang, X. (2006). Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method. Int J Pharm. 317: 40–46.
   PubMed Web of Science ®Google Scholar
• Vyas, T.K., Shahiwala, A., Marathe, S., Misra, A. (2005). Intranasal drug delivery for brain targeting. Curr Drug Deliv. 2:165–175.
   PubMedGoogle Scholar
• Yu, C., Meng, J., Chen, J., Tang, X. (2009). Preparation of ergoloid mesylate submicron emulsions for enhancing nasal absorption and reducing nasal ciliotoxicity. Int J Pharm. 375: 16–21.
   PubMed Web of Science ®Google Scholar
• Zhang, Q., Jiang, X., Xiang, W., Lu, W., Su, L., Shi, Z. (2004). Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation of the targeting efficiency to brain. Int. J. Pharm. 275: 85–96.
   PubMed Web of Science ®Google Scholar